Home » Clinical Trials » Location » Utah
West Jordan, Utah Clinical Trials
A listing of West Jordan, Utah clinical trials actively recruiting patient volunteers.
Found (4) clinical trials
Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
This Phase 4, double-blind, randomized, placebo-controlled, multicenter study is being undertaken at up to 170 sites internationally to evaluate the effect of OCA on clinical outcomes in 428 subjects with PBC. The study will include a screening period of up to 8 weeks, requiring two clinic visits. Eligible participants will ...
3.6 miles
A Clinical Trial of KT07 Capsule in the U.S.A
The purpose of this study is to investigate clinical efficacy of KT07 capsule in alleviation of fever and other symptoms including nasal congestion, sore throat, cough, aches and pains, fatigue, headache, chills or sweats in subjects with acute uncomplicated influenza.
3.92 miles
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
PRIMARY OBJECTIVES: I. To evaluate whether adjuvant therapy with crizotinib will result in improved overall survival (OS) for patients with stage IB >= 4 cm, II and IIIA, ALK-positive non-small cell lung cancer (NSCLC) following surgical resection. SECONDARY OBJECTIVES: I. To evaluate and compare disease-free survival (DFS) associated with crizotinib. ...
4.14 miles
Patients are needed to participate in a clinical research study of Ovarian Endometrioid Adenocarcinoma, Deleterious BRCA2 Gene Mutation, Recurrent Ovarian Carcinoma, Ovarian Seromucinous Carcinoma, Fallopian Tube Transitional Cell Carcinoma, Recurrent Primary Peritoneal Carcinoma, Undifferentiated Ovarian Carcinoma, Ovarian Transitional Cell Carcinoma, Recurrent Fallopian Tube Carcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Primary Peritoneal Serous Adenocarcinoma, Ovarian Serous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Ovarian Clear Cell Adenocarcinoma, Undifferentiated Fallopian Tube Carcinoma, Fallopian Tube Clear Cell Adenocarcinoma, Deleterious BRCA1 Gene Mutation to evaluate Paclitaxel, Olaparib, Pegylated Liposomal Doxorubicin Hydrochloride, Cediranib Maleate, Topotecan Hydrochloride
PRIMARY OBJECTIVES: I. To assess the efficacy and identify (in)active arm(s) of the combination of cediranib maleate (cediranib) and olaparib, cediranib alone, olaparib alone, and physician's choice standard of care chemotherapy, as measured by progression-free survival (PFS) in the setting of recurrent platinum-resistant or-refractory ovarian, primary peritoneal or fallopian tube ...
4.55 miles
